Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Association of Paraoxonase 1 Activities, Serum Mrna Expression and Polymorphisms With In-Stent Coronary Restenosis; a Case-Control Study Publisher



Soflaei SS1 ; Baktashian M2, 3 ; Saberikarimian M1 ; Esmaily H4, 5 ; Moohebati M6 ; Ebrahimi M6 ; Gholoobi A7, 8 ; Hashemi SM9 ; Ghazizadeh H1 ; Ferns GA10 ; Salehi M11 ; Pasdar A8, 12 ; Ghayourmobarhan M1, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. National Center for Health Insurance Reseasrch, Tehran, Iran
  3. 3. Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Department of Biostatistics and Epidemiology, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Cardiovascular Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  7. 7. Metabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  9. 9. Department of Cardiology, Chamran Hospital, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  10. 10. Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex, BN1 9PH, United Kingdom
  11. 11. Department of genetics, Faculty of medicine and genetics laboratory AL Zahra hospital, Isfahan University of medicine, Isfahan, Iran
  12. 12. Division of Applied Medicine, Medical School, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom

Source: Gene Reports Published:2023


Abstract

Background: PON1 polymorphisms and enzyme activity have been reported to be associated with cardiovascular disease (CVD). The aim of current study was to assess the association of these PON1 SNPs and serum enzyme activity and with restenosis following coronary artery stenting. Methods: A total of 306 unrelated Iranian patients with history of coronary stent implantation who underwent elective re-angiography were enrolled in the current study. Three single nucleotide polymorphisms (SNPs) of PON1 gene were genotyped. We used a double ARMS PCR method for genotyping at the Q192R and L55M loci, and PCR-RFLP method for C-108 T. Serum mRNA expression of PON1 was determined using SYBER green method and Roche LightCycler. Results: There were 104 patients considered as in-stent restenosis (ISR) (mean age: 60.55 ± 8.60 years), and 202 individuals as non ISR (NISR) (mean age: 61.94 ± 9.18 years). There were no significant difference between paraoxonase and arylestrase actvities of paraoxonase 1 enzyme. Furthermore, there were no significant differences in the distribution of genotypes of PON1 polymorphism with ISR compared to the control group. The AAC haplotype was the most frequent haplotype in our population study, and haplotypes were not associated with ISR occurrence. The difference between serum mRNA expression of PON1 was not significant between ISR and NISR groups. Conclusions: According to our finding it seems that paraoxonase 1 activities, the most important polymorphisms of PON1 including Q192R, L55M and C-108 T and serum mRNA expression of PON1 are not beneficial markers for ISR diagnosis. © 2023 Elsevier Inc.
Experts (# of related papers)
Other Related Docs
15. Association Between Severity of Coronary Disease and Apolipoproteins a and B, Iranian Journal of Endocrinology and Metabolism (2011)